Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
44 participants
OBSERVATIONAL
2018-09-01
2021-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Echocardiographic Right Ventricular Evaluation in Assessment of ARDS Lung Recruitment (ECHO-REVEAL)
NCT06812949
Evaluation of Three Dimensional Echocardiography in Critical Care Medicine
NCT03270319
Evaluation of Acute Cardiogenic Dyspnoea With Thorax Echography and Pro-BNP in the Emergency Department
NCT02122640
Diaphragmatic Echography in Critically Ill patientS
NCT02696018
Personalized Mechanical Ventilation Guided by UltraSound in Patients With Acute Respiratory Distress Syndrome
NCT05492344
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Definitions and pathophysiology Diastolic heart failure is defined as a condition caused by increased resistance to the filling of one or both ventricles; this leads to symptoms of congestion from the inappropriate upward shift of the diastolic pressure-volume relation. Although this definition describes the principal pathophysiologic mechanism of diastolic heart failure, it is not clinically applicable. In a more practical definition diastolic heart failure is a condition that includes classic congestive heart failure findings with normal systolic function at rest, but with alteration in diastolic function. During DD the combination of active relaxation and passive myocardial compliance that normally maintain an adequate cardiac output are altered and left atrial pressure should be increased to maintain a satisfactory cardiac output. Different parameters have been used over the past two decades to describe the DD, so it is difficult to define its real incidence in critically ill patients. It seems to occur in about 30% of cases, and the majority of the studies tend to relate it with concomitant syndrome such as sepsis or clinical conditions such as respiratory weaning failure.
Left Diastolic dysfunction in ICU Most of the literature available investigated left DD in septic patient, and even if in the majority of these studies the patients were mechanically ventilated, only few information are available about the role of mechanical ventilation (MV) or the acute phase of lung injury.
With The advent of tissue Doppler imaging (TDI) has simplified echocardiographic estimation of ventricular relaxation and ventricular filling pressures, and the increasing number of studies in the field have showed that diastolic dysfunction is common in critically ill patients. The significance of diastolic dysfunction was recently highlighted by studies that demonstrated that TDI parameters might be prognostically useful in ICU population. More recent observations may help to clarify the scenario in these terms. An alteration in the E/e' ratio has been described in patients with septic shock and, although one study found that the E/e' ratio is an independent predictor of mortality \[20\], another investigation failed to find this association.
Left diastolic dysfunction in mechanical ventilated and ARDS patients It is well known that mechanical ventilation can induce hemodynamic compromise and that myocardial dysfunction and its consequences are not properly reflected by conventional hemodynamic parameters. Myocardial function can be assessed at the bedside using transthoracic echocardiography (TTE); however, the 2D echocardiographic measurements have been used to investigate predominantly the effects on systolic rather than diastolic ventricular function. Recently, TDI has provided more load-independent parameters to assess cardiac function, but its use is not widespread in ICU. For these reasons and probably because DD is greatly underestimated, there are few paper focused on mechanical ventilation and DD, most of them during weaning period, and almost none during the acute phase. What we know is that positive pressure ventilation can affect preload, afterload and ventricular compliance. The net effect in most situations is a decrease in cardiac output. However, the effect may be beneficial in the context of decompensated heart failure, where the decreased preload and afterload result in a return to a more productive part of the Starling curve.
More it is known in patients with prolonged weaning time. In this scenario, isolated diastolic dysfunction is present in about 22% up to 39% of patients. The increase in preload and afterload during MV may impair the LV compliance and determine a pulmonary edema. The fall in LV pressure during relaxation phase is a key determinant of diastolic function, and depends on intrinsic (contractility, LV stiffness) and extrinsic (preload, afterload) factors. Recently, has been suggested how the LV relaxation impairment with increased filling pressures may be a key mechanism of failed prolonged weaning trials. To summarize all these evidence, we could state that the elimination of positive ventilation increases LV preload and afterload and may induce some physiologic changes that can determine tachycardia and hypertension. Those are coincidentally two major determinants of diastolic dysfunction, as higher heart frequency reduces diastolic filling time and/or decreases coronary perfusion, and hypertension can exacerbate heart failure in patients with preserved ejection fraction. These findings suggest that echocardiography could be an excellent tool to guide the weaning process, helping to decide the best therapy to accomplish it.
Methods Consecutive mechanically ventilated patients will be enrolled within 48 hours after ICU admission with the diagnosis of ARDS. Demographic characteristics and respiratory mechanics variables (including esophageal pressure) will be recorded at two levels of positive end-expiratory pressure (PEEP); all patients will be study by a CT analysis at two levels of PEEP (5-45 cmh20) for the evaluation of recruitment potential, together with the computation of functional residual capacity (FRC). A well-trained cardiologist will perform a completed transthoracic echocardiography with the aim to describe the presence and the grade of left ventricular diastolic dysfunction (LVDD) applying a simplified definition of left DD, based on septal e', which is considered to be an index of myocardial relaxation, and the ratio of early diastolic velocity of mitral inflow to mitral annular velocity (E/e'), which has a strong association with left atrial pressure.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
echocariographic ultrasound
left ventricular diastolic function description
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Milan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Davide Chiumello
Prof
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
ASST-Santi Paolo e Carlo, San Paolo Hospital
Milan, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ARDS-ECHO
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.